Cell Signaling Technology Inc

Cell Signaling Technology, Inc. is a leading provider of high-quality antibodies and related products, specializing in innovative solutions for research in various fields such as cancer, immunology, and neuroscience. With over 25 years of experience, the company is recognized for its commitment to product performance, reliability, and environmental and social responsibility. The company offers an extensive catalog of recombinant monoclonal antibodies, custom services, and cutting-edge technologies like InTraSeq, designed to enhance single-cell biology research. Their resources also include educational materials, technical support, and a focus on advancing drug discovery and development solutions. Generated from the website

Established in 1999, Cell Signaling Technology Inc. is a privately owned life science company. It provides various research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, Cell Signaling Technology Inc. has become one of the world leaders in the production of the highest quality activation-state antibodies utilized to expand knowledge of cell signaling pathways. Some of the registered trademarks of the company include AcetylScan, PhosphoPlus, StemLite, UbiScan and many more.